| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |